Ignite Creation Date:
2024-05-05 @ 11:11 PM
Last Modification Date:
2024-10-26 @ 10:30 AM
Study NCT ID:
NCT01277549
Status:
COMPLETED
Last Update Posted:
2013-05-03
First Post:
2011-01-13
Brief Title:
Evaluation of the Spectra Optia Apheresis System Mononuclear Cell MNC Collection Procedure in Healthy Blood Donors
Sponsor:
Terumo BCT
Organization:
Terumo BCT
Study Overview
Official Title:
Evaluation of the Spectra Optia Apheresis System Mononuclear Cell MNC Collection Procedure in Healthy Blood Donors
Status:
COMPLETED
Status Verified Date:
2013-05
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this protocol is to characterize the performance of CaridianBCTs Spectra Optia Apheresis System when used to collect mononuclear cells MNCs and cluster of differentiation 34 CD34 positive cells from healthy nonmobilized blood donors and healthy G-CSF granulocyte colony stimulating factor mobilized blood donors respectively
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None